Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Reply to "When Is a Ketogenic Diet Ketogenic? Comment on Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients. Nutrients 2019, 11, 1156".

Benlloch M, López-Rodríguez MM, Cuerda-Ballester M, Drehmer E, Carrera S, Ceron JJ, Tvarijonaviciute A, Chirivella J, Fernández-García D, de la Rubia Ortí JE.

Nutrients. 2019 Aug 15;11(8). pii: E1919. doi: 10.3390/nu11081919.

2.

Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients.

Benlloch M, López-Rodríguez MM, Cuerda-Ballester M, Drehmer E, Carrera S, Ceron JJ, Tvarijonaviciute A, Chirivella J, Fernández-García D, de la Rubia Ortí JE.

Nutrients. 2019 May 23;11(5). pii: E1156. doi: 10.3390/nu11051156.

3.

Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study.

de la Rubia JE, Drehmer E, Platero JL, Benlloch M, Caplliure-Llopis J, Villaron-Casales C, de Bernardo N, AlarcÓn J, Fuente C, Carrera S, Sancho D, GarcÍa-Pardo P, Pascual R, JuÁrez M, Cuerda-Ballester M, Forner A, Sancho-Castillo S, Barrios C, Obrador E, Marchio P, Salvador R, Holmes HE, Dellinger RW, Guarente L, Estrela JM.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):115-122. doi: 10.1080/21678421.2018.1536152. Epub 2019 Jan 22.

PMID:
30668199
4.

Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.

Estrela JM, Mena S, Obrador E, Benlloch M, Castellano G, Salvador R, Dellinger RW.

J Med Chem. 2017 Dec 14;60(23):9413-9436. doi: 10.1021/acs.jmedchem.6b01026. Epub 2017 Jul 11.

PMID:
28654265
5.

Impact of the Relationship of Stress and the Immune System in the Appearance of Alzheimer's Disease.

de la Rubia Ortí JE, Sancho Castillo S, Benlloch M, Julián Rochina M, Corchón Arreche S, García-Pardo MP.

J Alzheimers Dis. 2017;55(3):899-903.

PMID:
27767997
6.

Pterostilbene Decreases the Antioxidant Defenses of Aggressive Cancer Cells In Vivo: A Physiological Glucocorticoids- and Nrf2-Dependent Mechanism.

Benlloch M, Obrador E, Valles SL, Rodriguez ML, Sirerol JA, Alcácer J, Pellicer JA, Salvador R, Cerdá C, Sáez GT, Estrela JM.

Antioxid Redox Signal. 2016 Jun 10;24(17):974-90. doi: 10.1089/ars.2015.6437. Epub 2016 Mar 15.

7.

Glucocorticoid receptor knockdown decreases the antioxidant protection of B16 melanoma cells: an endocrine system-related mechanism that compromises metastatic cell resistance to vascular endothelium-induced tumor cytotoxicity.

Obrador E, Valles SL, Benlloch M, Sirerol JA, Pellicer JA, Alcácer J, Coronado JA, Estrela JM.

PLoS One. 2014 May 6;9(5):e96466. doi: 10.1371/journal.pone.0096466. eCollection 2014.

8.

Stress hormones promote growth of B16-F10 melanoma metastases: an interleukin 6- and glutathione-dependent mechanism.

Valles SL, Benlloch M, Rodriguez ML, Mena S, Pellicer JA, Asensi M, Obrador E, Estrela JM.

J Transl Med. 2013 Mar 22;11:72. doi: 10.1186/1479-5876-11-72.

9.

Intertissue flow of glutathione (GSH) as a tumor growth-promoting mechanism: interleukin 6 induces GSH release from hepatocytes in metastatic B16 melanoma-bearing mice.

Obrador E, Benlloch M, Pellicer JA, Asensi M, Estrela JM.

J Biol Chem. 2011 May 6;286(18):15716-27. doi: 10.1074/jbc.M110.196261. Epub 2011 Mar 10.

10.

Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: a Bcl-2- and superoxide dismutase 2-dependent mechanism.

Priego S, Feddi F, Ferrer P, Mena S, Benlloch M, Ortega A, Carretero J, Obrador E, Asensi M, Estrela JM.

Mol Cancer Ther. 2008 Oct;7(10):3330-42. doi: 10.1158/1535-7163.MCT-08-0363.

11.

Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease.

Mena S, Benlloch M, Ortega A, Carretero J, Obrador E, Asensi M, Petschen I, Brown BD, Estrela JM.

Clin Cancer Res. 2007 May 1;13(9):2658-66.

12.

Nitric oxide mediates natural polyphenol-induced Bcl-2 down-regulation and activation of cell death in metastatic B16 melanoma.

Ferrer P, Asensi M, Priego S, Benlloch M, Mena S, Ortega A, Obrador E, Esteve JM, Estrela JM.

J Biol Chem. 2007 Feb 2;282(5):2880-90. Epub 2006 Nov 29.

13.

Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor-alpha and chemotherapy.

Benlloch M, Mena S, Ferrer P, Obrador E, Asensi M, Pellicer JA, Carretero J, Ortega A, Estrela JM.

J Biol Chem. 2006 Jan 6;281(1):69-79. Epub 2005 Nov 1.

14.

Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma.

Ferrer P, Asensi M, Segarra R, Ortega A, Benlloch M, Obrador E, Varea MT, Asensio G, Jordá L, Estrela JM.

Neoplasia. 2005 Jan;7(1):37-47.

15.

Acceleration of glutathione efflux and inhibition of gamma-glutamyltranspeptidase sensitize metastatic B16 melanoma cells to endothelium-induced cytotoxicity.

Benlloch M, Ortega A, Ferrer P, Segarra R, Obrador E, Asensi M, Carretero J, Estrela JM.

J Biol Chem. 2005 Feb 25;280(8):6950-9. Epub 2004 Nov 22.

Supplemental Content

Loading ...
Support Center